Related Experiment Video
Updated: Jun 3, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
5-year survival after multiple repeat metastasectomy for pulmonary artery angiosarcoma
Sameh M Said1, Thoralf M Sundt, Yolanda I Garces
1Division of General Thoracic Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA. said.sameh@mayo.edu
The Annals of Thoracic Surgery
|March 29, 2011
Summary
Primary pulmonary artery angiosarcomas are rare and aggressive. This case highlights long-term survival in a patient with pulmonary artery angiosarcoma after multiple surgeries.
Area of Science:
- Cardiovascular Surgery
- Surgical Oncology
- Thoracic Oncology
Background:
- Primary pulmonary artery angiosarcomas are exceptionally rare malignant vascular tumors.
- These tumors have a historically poor prognosis with limited treatment options and survival rates.
Observation:
- A case study of a 39-year-old female patient diagnosed with primary pulmonary artery angiosarcoma.
- The patient underwent multiple metastasectomies and a pulmonary artery tumor endarterectomy.
Findings:
- The patient achieved no evidence of disease status 5 years post-diagnosis.
- This represents a rare instance of long-term survival for this aggressive malignancy.
Implications:
- Aggressive surgical management, including metastasectomy and endarterectomy, may contribute to improved outcomes.
- This case suggests potential for long-term survival in select patients with pulmonary artery angiosarcoma.
- Further research into optimal treatment strategies for primary pulmonary artery angiosarcoma is warranted.
